TetraLogic Pharmaceuticals Corporation (NasdaqGM:TLOG) is seeking acquisitions. TetraLogic announces pricing of $25 million of public offering. TetraLogic Pharmaceuticals said in Sec Filling, TetraLogic anticipates using the net proceeds from the offering for general corporate purposes, including working capital, continued development of its product candidate pipeline, acquisitions and other business opportunities.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | -99.00% |
1st Jan change | Capi. | |
---|---|---|
-99.00% | 24 | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- TLOG Stock
- News TetraLogic Pharmaceuticals Corporation
- TetraLogic Pharmaceuticals Mulls Acquisitions